Some investors may be asking whether CVS Health offers good value at around its recent price, or whether much of the potential upside in the stock has already been realized. Over the past year, CVS ...

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health next reports earnings pre-market on Feb. 10. Shares in the healthcare giant also fell on the latest Medicare Advantage payments news, which could affect the stock on earnings day. Although ...

Jefferies sets a 'Buy' on Shriram Finance, citing strong CV demand and growth outlook—discover the latest target and rationale here.

The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.

Therefore, the most likely Salesforce stock price forecast is bearish, with the initial target being $150. In the future, ...

CVS Health (NYSE:CVS) has launched Health100, an AI powered digital health platform, through a new subsidiary. The platform is being developed in major partnership with Google Cloud to connect ...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...

CVS Health Corporation is rated a Hold, reflecting balanced risk and income potential amid persistent Medicare Advantage cost pressures. Q4 2025 saw record revenue, but rising medical costs in Aetna ...

CEO Mark Bertolini has been making the same promise for four consecutive quarters: 2026 is the year the company turns profitable. Now, with the Q4 2025 results in hand, we can see exactly what he’s ...

The retirement of David Cordani as CEO of The Cigna Group will be the fourth departure of a long-time health insurance ...